These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 3344851)

  • 1. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
    Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
    Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance of the brain and Achilles tendon in cerebrotendinous xanthomatosis].
    Pardo J; Prieto JM; Rodríguez JR; Vadillo J; Dapena MD; Noya M
    Neurologia; 1993 Oct; 8(8):268-70. PubMed ID: 8240840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
    Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
    Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
    J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM; Salen G; Shefer S
    N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebrotendinous xanthomatosis].
    Berginer VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrotendinous xanthomatosis].
    Baumgartner RW; Hauser V; Grob P; Waespe W
    Schweiz Med Wochenschr; 1991 Jun; 121(23):858-64. PubMed ID: 1857943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
    Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S
    Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Berginer V
    Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].
    Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P
    Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
    Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
    Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebrotendinous xanthomatosis. 2 cases with magnetic resonance imaging].
    Rogelet P; Gérard JM; Michotte A; Masingue M; Destée A
    Rev Neurol (Paris); 1992; 148(8-9):541-5. PubMed ID: 1494725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
    Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
    Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrotendinous xanthomatosis is treatable.
    White SW
    Pediatr Dermatol; 1985 Jul; 2(4):294-6. PubMed ID: 3925446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrotendinous xanthomatosis. A case report].
    Sabadini L; Gonnelli L; Anichini C; Funtò I; Marcolongo R; Dotti MG; Federico A
    Recenti Prog Med; 1996 Mar; 87(3):110-3. PubMed ID: 8650430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis.
    Salen G; Meriwether TW; Nicolau G
    Biochem Med; 1975 Sep; 14(1):57-74. PubMed ID: 1212241
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
    Preiss Y; Santos JL; Smalley SV; Maiz A
    Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.